• Stanford’s StartX joins Covid-19 response with task force pharmaceutical-technology
    March 20, 2020
    Stanford University non-profit start-up StartX has launched StartX Med Covid-19 task force to mobilise 70 experts in the university’s community to collaborate on and fast track preventive ...
  • Using CRISPR to predict heart disease risk fiercebiotech
    June 25, 2018
    There are about 135 genes associated with cardiomyopathy and congenital heart conditions that can cause sudden death.
  • Takeda Announces Alliance with Stanford University americanpharmaceuticalreview
    August 16, 2017
    Takeda announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform novel Stanford research into next-generation treatments for diseases.
PharmaSources Customer Service